Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Neomorphic Gαo mutations gain interaction with Ric8 proteins in GNAO1 encephalopathies
Gonzalo P. Solis, … , Mikhail Savitsky, Vladimir L. Katanaev
Gonzalo P. Solis, … , Mikhail Savitsky, Vladimir L. Katanaev
Published June 14, 2024
Citation Information: J Clin Invest. 2024;134(15):e172057. https://doi.org/10.1172/JCI172057.
View: Text | PDF
Research Article Cell biology Genetics Article has an altmetric score of 6

Neomorphic Gαo mutations gain interaction with Ric8 proteins in GNAO1 encephalopathies

  • Text
  • PDF
Abstract

GNAO1 mutated in pediatric encephalopathies encodes the major neuronal G protein Gαo. Of the more than 80 pathogenic mutations, most are single amino acid substitutions spreading across the Gαo sequence. We performed extensive characterization of Gαo mutants, showing abnormal GTP uptake and hydrolysis and deficiencies in binding Gβγ and RGS19. Plasma membrane localization of Gαo was decreased for a subset of mutations that leads to epilepsy; dominant interactions with GPCRs also emerged for the more severe mutants. Pathogenic mutants massively gained interaction with Ric8A and, surprisingly, Ric8B proteins, relocalizing them from cytoplasm to Golgi. Of these 2 mandatory Gα-subunit chaperones, Ric8A is normally responsible for the Gαi/Gαo, Gαq, and Gα12/Gα13 subfamilies, and Ric8B solely responsible for Gαs/Gαolf. Ric8 mediates the disease dominance when engaging in neomorphic interactions with pathogenic Gαo through imbalance of the neuronal G protein signaling networks. As the strength of Gαo-Ric8B interactions correlates with disease severity, our study further identifies an efficient biomarker and predictor for clinical manifestations in GNAO1 encephalopathies. Our work uncovers the neomorphic molecular mechanism of mutations underlying pediatric encephalopathies and offers insights into other maladies caused by G protein malfunctioning and further genetic diseases.

Authors

Gonzalo P. Solis, Alexey Koval, Jana Valnohova, Arghavan Kazemzadeh, Mikhail Savitsky, Vladimir L. Katanaev

×

Figure 1

Spectrum of biochemical defects associated with GNAO1 encephalopathy mutations.

Options: View larger image (or click on image) Download as PowerPoint
Spectrum of biochemical defects associated with GNAO1 encephalopathy mut...
(A) Scheme of the mutated amino acid residues (stars) in the overall sequence of Gαo. The residues are either located in the P-loop or in the Ras-like domain. (B and C) Representative curves of BODIPY-GTPγS binding to wild-type Gαo, encephalopathy mutants, and the GTPase-dead Q205L mutant (used as control). Most of the Gαo mutants present strongly elevated binding rates — dotted-line box in B, expanded in C — whereas only 2 mutants (C215Y and Y231C) display nearly wild-type rates. (D) Quantification of the binding rate constant (kbind) of Gαo variants color-coded according to their association with developmental and epileptic encephalopathy-17 (DEE17; red) or neurodevelopmental disorder with involuntary movements (NEDIM; blue). (E and F) Representative curves of the course of BODIPY-GTP binding and hydrolysis by wild-type Gαo and active (E) or deficient/dead (F) mutants. (G) Quantification of the hydrolysis rate constant (khydr). Note that data are adjusted to the plateau to highlight the differences in the binding rates in B and C, while raw fluorescence units are shown in E and F, which are needed for the proper khydr calculation. Data in D and G represent mean ± SD (n = 3). NS, not significant. *P < 0.05, ****P < 0.0001 by 1-way ANOVA followed by Dunnett’s multiple-comparison test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 6 X users
On 1 Facebook pages
4 readers on Mendeley
See more details